These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 26477868)

  • 1. A Cost-Effectiveness Analysis of a Pilot Neonatal Screening Program for Sickle Cell Anemia in the Republic of Angola.
    McGann PT; Grosse SD; Santos B; de Oliveira V; Bernardino L; Kassebaum NJ; Ware RE; Airewele GE
    J Pediatr; 2015 Dec; 167(6):1314-9. PubMed ID: 26477868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective newborn screening and treatment program for sickle cell anemia in Luanda, Angola.
    McGann PT; Ferris MG; Ramamurthy U; Santos B; de Oliveira V; Bernardino L; Ware RE
    Am J Hematol; 2013 Dec; 88(12):984-9. PubMed ID: 24038490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early diagnosis of sickle cell disease at birth hospitals and vaccination centers in Angola using point-of-care tests.
    Olaniyan HS; Briscoe C; Muhongo M; Pascoal R; Armando A; Santos B; McGann PT
    Blood Adv; 2023 Oct; 7(19):5860-5867. PubMed ID: 37399450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newborn screening coupled with comprehensive follow-up reduced early mortality of sickle cell disease in Connecticut.
    Frempong T; Pearson HA
    Conn Med; 2007 Jan; 71(1):9-12. PubMed ID: 17288099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newborn screening for sickle cell disease: an innovative pilot program to improve child survival in Dar es Salaam, Tanzania.
    Nkya S; Mtei L; Soka D; Mdai V; Mwakale PB; Mrosso P; Mchoropa I; Rwezaula S; Azayo M; Ulenga N; Ngido M; Cox SE; D'Mello BS; Masanja H; Kabadi GS; Mbuya F; Mmbando B; Daniel Y; Streetly A; Killewo J; Tluway F; Lyimo M; Makani J
    Int Health; 2019 Nov; 11(6):589-595. PubMed ID: 31145786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost-effectiveness of expanding newborn screening for up to 21 inherited metabolic disorders using tandem mass spectrometry: results from a decision-analytic model.
    Cipriano LE; Rupar CA; Zaric GS
    Value Health; 2007; 10(2):83-97. PubMed ID: 17391418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-Effectiveness Analysis of a National Newborn Screening Program for Biotinidase Deficiency.
    Vallejo-Torres L; Castilla I; Couce ML; Pérez-Cerdá C; Martín-Hernández E; Pineda M; Campistol J; Arrospide A; Morris S; Serrano-Aguilar P
    Pediatrics; 2015 Aug; 136(2):e424-32. PubMed ID: 26169436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of a Low-Cost Paper-Based Screening Test for Sickle Cell Anemia.
    Piety NZ; Yang X; Kanter J; Vignes SM; George A; Shevkoplyas SS
    PLoS One; 2016; 11(1):e0144901. PubMed ID: 26735691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic evaluation of tandem mass spectrometry screening in California.
    Feuchtbaum L; Cunningham G
    Pediatrics; 2006 May; 117(5 Pt 2):S280-6. PubMed ID: 16735254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal screening for sickle cell disease: a cost-effectiveness analysis.
    Tsevat J; Wong JB; Pauker SG; Steinberg MH
    J Pediatr; 1991 Apr; 118(4 Pt 1):546-54. PubMed ID: 1901081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-Effectiveness/Cost-Benefit Analysis of Newborn Screening for Severe Combined Immune Deficiency in Washington State.
    Ding Y; Thompson JD; Kobrynski L; Ojodu J; Zarbalian G; Grosse SD
    J Pediatr; 2016 May; 172():127-35. PubMed ID: 26876279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of a multicenter universal newborn screening program for sickle cell disease in Italy: A call to action.
    Colombatti R; Martella M; Cattaneo L; Viola G; Cappellari A; Bergamo C; Azzena S; Schiavon S; Baraldi E; Dalla Barba B; Trafojer U; Corti P; Uggeri M; Tagliabue PE; Zorloni C; Bracchi M; Biondi A; Basso G; Masera N; Sainati L
    Pediatr Blood Cancer; 2019 May; 66(5):e27657. PubMed ID: 30724025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cost-effectiveness evaluation of newborn hemoglobinopathy screening from the perspective of state health care systems.
    Gessner BD; Teutsch SM; Shaffer PA
    Early Hum Dev; 1996 Jul; 45(3):257-75. PubMed ID: 8855399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fifteen years of newborn sickle cell disease screening in Madrid, Spain: an emerging disease in a European country.
    García-Morín M; Bardón-Cancho EJ; Beléndez C; Zamarro R; Béliz-Mendiola C; González-Rivera M; Vecilla C; Llorente-Otones L; Pérez-Alonso V; Román SS; Sebastián E; Dulín E; Cela E
    Ann Hematol; 2020 Jul; 99(7):1465-1474. PubMed ID: 32451712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of neonatal screening for sickle cell disorders on lifetime treatment costs and early deaths avoided: a modelling approach.
    Karnon J; Zeuner D; Ades AE; Efimba W; Brown J; Yardumian A
    J Public Health Med; 2000 Dec; 22(4):500-11. PubMed ID: 11192278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newborn Screening for Sickle Cell Disease in Liberia: A Pilot Study.
    Tubman VN; Marshall R; Jallah W; Guo D; Ma C; Ohene-Frempong K; London WB; Heeney MM
    Pediatr Blood Cancer; 2016 Apr; 63(4):671-6. PubMed ID: 26739520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal screening and clinical care programmes for sickle cell disorders in sub-Saharan Africa: lessons from pilot studies.
    Tshilolo L; Kafando E; Sawadogo M; Cotton F; Vertongen F; Ferster A; Gulbis B
    Public Health; 2008 Sep; 122(9):933-41. PubMed ID: 18555498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost effectiveness of newborn screening for cystic fibrosis: a simulation study.
    Nshimyumukiza L; Bois A; Daigneault P; Lands L; Laberge AM; Fournier D; Duplantie J; Giguère Y; Gekas J; Gagné C; Rousseau F; Reinharz D
    J Cyst Fibros; 2014 May; 13(3):267-74. PubMed ID: 24238947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Primary care follow-up of newborns with sickle cell disease detected in neonatal screening in the Community of Madrid].
    Rodríguez-Moldes B; Carbajo AJ; Sánchez B; Fernández M; Garí M; Fernández MC; Álvarez J; García A; Cela E
    An Pediatr (Barc); 2015 Apr; 82(4):222-7. PubMed ID: 24840253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementing newborn screening for sickle cell disease in Korle Bu Teaching Hospital, Accra: Results and lessons learned.
    Segbefia CI; Goka B; Welbeck J; Amegan-Aho K; Dwuma-Badu D; Rao S; Salifu N; Oppong SA; Odei E; Ohene-Frempong K; Odame I
    Pediatr Blood Cancer; 2021 Jul; 68(7):e29068. PubMed ID: 33890391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.